| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |